MyoKardia - 49 Year Dividend History | MYOK

Historical dividend payout and yield for MyoKardia (MYOK) since 1971. The current TTM dividend payout for MyoKardia (MYOK) as of January 17, 2020 is $0.00. The current dividend yield for MyoKardia as of January 17, 2020 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $3.475B $0.034B
MyoKardia, Inc. is a biopharmaceutical company. The company focuses on discovering, developing, and commercializing therapies for the treatment of serious and neglected rare cardiovascular diseases. Its product candidate consists of MYK-461, a small molecule to reduce excessive cardiac muscle contractility leading to hypertrophic cardiomyopathy, DCM-1, treats heritable dilated cardiomyopathy by restoring normal contractility in the diseased DCM heart, HCM-2, a product candidate to reduce cardiac muscle contractility to normal levels in HCM patients and LUS-1, which is intended to counteract a muscle disruption that results in impaired relaxation of the heart, which are in different clinical trial. MyoKardia, Inc. is headquartered in San Francisco, California.
Stock Name Country Market Cap PE Ratio